Built Target Product Profile (TPP) that guided regulatory program
Completed product positioning and pricing research
Developed comprehensive launch plan
Pricing strategy
Specialized hospital distribution network
Sales force sizing, deployment and incentives
Marketing plan
Supported medical affairs and future publication planning
Launched product to cardiac electrophysiologists
Market assessment / research including competitive landscape
Collaborated with clinical development partner to support Phase 2-3 study objectives
Built pre-commercial plan including field deployment and budgets
Developed target product profile (TPP)
Created launch plan / go-to-market strategy
Pricing strategy
Distribution plan
Sales force sizing
Marketing plan
Built financial, valuation including gross-to-net calculations
Supported due diligence and licensing negotiations
Successfully in-licensed product
Created licensing strategy to secure IP and terms from large pharma
Restarted dated CMC program
Refocused clinical development from original oncology program to rare (Orphan) endocrine indication
Re-engineered regulatory strategy
Developed material for fundraising activities (pitch decks)
Built financial and valuation models
Created Phase 2b/3 clinical development and pre-commercial plan
Secured Series A venture-backed raise of >$30M ($100M valuation)
Comprehensive market and product assessment
Primary and secondary market research
Developed target product profile (TPP) and product positioning
Created launch plan
Pricing strategy
Distribution plan
Sales force sizing
Marketing plan
Built financial and valuation models
Successful product out-licensing